• English
  • Français

News

Category

Sofinn Group Announce Strategic Cooperation Agreement with Aqua-Nova

 

 

 

Pharmtec SA, a subsidiary of the Sofinn Group, is excited to announce a strategic cooperation agreement with Aqua-Nova AB of Sweden. This significant partnership will commence on November 1, 2023, marking a new era in the manufacturing, marketing, and selling of Aqua-Nova’s innovative water purification products.

Aqua-Nova AB, known for its expertise in creating multiple effect water stills and pure steam generators, holds the ownership of the Aqua-Nova brand. This collaboration with Pharmtec SA, an industry leader in hot water WFI products, hot sterilisation, and effluent decontamination solutions, is poised to redefine standards in the pharmaceutical industry.

The agreement signifies a deepening of the existing relationship between the two companies, where Pharmtec has already established itself as a pivotal contributor to Aqua-Nova’s growth and success as the brand’s exclusive agent in France. This new chapter in their partnership will further leverage SofinnĂ€s sales expertise, especially in the demanding international pharmaceutical sector.

As part of the agreement, Pharmtec SA will manufacture Aqua-Nova’s products, contributing to the brand’s expanding global footprint.

Gunnar BjörkstĂ©n, owner of the Sofinn Group and joint majority owner of Aqua-Nova AB with Lennart KĂ€rrberg, expressed his enthusiasm for this partnership. “This agreement represents a fusion of strengths. Combining Pharmtec’s sales prowess and Aqua-Nova’s innovative technology, we are set to make significant strides in the pharmaceutical industry,” he stated.

You might be interested in...

These washers provide thorough, consistent cleaning for a variety of vial sizes. These machines blend high-performance washing capabilities with a user-friendly interface and robust construction, making them indispensable for hygiene and quality in the production line.
Unlock higher performance and compliance with our upgrade services. Control system refinements and risk assessments, we revamp your existing equipment for optimal efficiency. Future-proof your operations with us."
Aqua-Nova, Multi-effect steam heated WFI Water Still, enables larger capacities than electrically powered systems. It combines efficient operation, low life cycle costs when producing WFI.

Our products

We excel in delivering pharmaceutical turnkey projects, with expertise in water sterilization, dry heat sterilizers, and more. Our deep industry knowledge and regulatory compliance ensure customized solutions that guarantee quality. Exceptional customer service and strategic project management ensure successful outcomes. In pharmaceuticals, our proven track record speaks for itself.

Aqua-Nova stills mark a significant leap in distillation technology with reduced steam velocity and enhanced performance. Their robust, reliable design, complete with modulating control valves for all fluids, guarantees optimal operation across all conditions.

Aqua-Nova’s ‘float’ type heat exchangers excel by completely submerging in water, preventing thermal stress that may lead to micro cracks. This design ensures uniform contraction and expansion of tubes and the mantle under consistent steam and water conditions.

Lytzen has been fully specialized in depyrogenation ovens for over 50 years. What makes Lytzen unique is their highly specialized knowledge in this special application of batch depyrogenation in chambers ranging from 590 liters to about 7000 liters.

Lyophilization, commonly known as freeze-drying, is a crucial process in the pharmaceutical and biotech industries. Maintaining product integrity is key. Mainly used for preservation of biologicals and drug formulation among many other things.

High-level containment powder transfer systems for the pharmaceutical industry. The products include powder filling and emptying stations, the PCC (Pro Clean Conveyor) pneumatic powder transfer system, and powder sampling devices.

Drawing on its expertise in the field of water treatment and heat sterilisation. Sofinn has through Pharmtec SA developed a new technology (patented) for effluent decontamination without pumps and heat exchangers, meeting BSL requirements for levels 1, 2, 3, and 4 with superior resistance to clogging.

The transferring of biopharmaceutical products, such as vaccines, monoclonal antibodies, or gene therapies, from bulk containers into their final dosage forms, which are typically vials, syringes, or other delivery systems is highly regulated and demands precision and sterility to ensure the quality and safety of the final product.

Sofinn provides service at all stages in the lifetime of the equipment, keeping the equipment in good working order and prolonging the lifetime of the installations. Carried out by our high quality, well-trained professionals with experience from the pharmaceutical industry.